Phase 1 Trial of Mutant proUK, M5, and Its Inhibitor, C1-inhibitor
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2017
At a glance
- Drugs TS 01 (Primary) ; M-5
- Indications Stroke; Thrombosis
- Focus Adverse reactions; First in man
- Sponsors Thrombolytic Science International
- 18 Sep 2017 Status changed from suspended to completed, according to a Thrombolytic Science media release.
- 12 Jan 2015 Planned End Date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 12 Jan 2015 Planned primary completion date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.